Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study

BACKGROUND: Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) has been considered as a promising treatment modality for gastric cancer with peritoneal carcinomatosis (PC). However, there have also been many debates regarding the efficacy and safety of this new approa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Li, Mei, Lie-Jun, Yang, Xiao-Jun, Huang, Chao-Qun, Zhou, Yun-Feng, Yonemura, Yutaka, Li, Yan
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098163/
https://www.ncbi.nlm.nih.gov/pubmed/21548973
http://dx.doi.org/10.1186/1479-5876-9-53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098163/
https://www.ncbi.nlm.nih.gov/pubmed/21548973
http://dx.doi.org/10.1186/1479-5876-9-53

Ejemplares similares